Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome
- 2 November 2016
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 38 (3), 260-264
- https://doi.org/10.1002/humu.23140
Abstract
Mutations in the thyroid hormone transporter SLC16A2 (MCT8) cause the Allan–Herndon–Dudley Syndrome (AHDS), characterized by severe psychomotor retardation and peripheral thyrotoxicosis. Here, we report three newly identified AHDS patients. Previously documented mutations were identified in probands 1 (p.R271H) and 2 (p.G564R), resulting in a severe clinical phenotype. A novel mutation (p.G564E) was identified in proband 3, affecting the same Gly564 residue, but resulting in a relatively mild clinical phenotype. Functional analysis in transiently transfected COS‐1 and JEG‐3 cells showed a near‐complete inactivation of TH transport for p.G564R, whereas considerable cell‐type‐dependent residual transport activity was observed for p.G564E. Both mutants showed a strong decrease in protein expression levels, but differentially affected Vmax and Km values of T3 transport. Our findings illustrate that different mutations affecting the same residue may have a differential impact on SLC16A2 transporter function, which translates into differences in severity of the clinical phenotype.This publication has 23 references indexed in Scilit:
- Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 MutationPLOS ONE, 2015
- Psychomotor Retardation Caused by a Defective Thyroid Hormone Transporter: Report of Two Families with Different MCT8 MutationsHormone Research in Paediatrics, 2014
- The Role of Arg445 and Asp498 in the Human Thyroid Hormone Transporter MCT8Endocrinology, 2014
- Histidines in Potential Substrate Recognition Sites Affect Thyroid Hormone Transport by Monocarboxylate Transporter 8 (MCT8)Endocrinology, 2013
- Genetics and phenomics of thyroid hormone transport by MCT8Molecular and Cellular Endocrinology, 2010
- Importance of Monocarboxylate Transporter 8 for the Blood-Brain Barrier-Dependent Availability of 3,5,3′-Triiodo-l-ThyronineEndocrinology, 2009
- Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardationThe Lancet, 2004
- A Novel Syndrome Combining Thyroid and Neurological Abnormalities Is Associated with Mutations in a Monocarboxylate Transporter GeneAmerican Journal of Human Genetics, 2004
- Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone TransporterJournal of Biological Chemistry, 2003
- Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and BioavailabilityEndocrine Reviews, 2001